Merck Prestige® 2 Equine Vaccine 10 mL/10 Dose

Merck Prestige® 2 Equine Vaccine 10 mL/10 Dose

INDICATIONS

This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against equine influenza (EIV), equine herpesvirus type 1 (EHV-1) and equine herpesvirus type 4 (EHV-4). Duration of immunity has been shown at 6 months for EIV.

• Formulated to minimize reactions and maximize protection
• Available in 10-dose vials and 1 mL single-dose prefilled syringes
• A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine herpesvirus types 1 and 4 (EHV-1 and EHV-4) and equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07.
• Advanced filtration process through the Antigen Purification System (APS™)
• Exceptional safety profile with the exclusive Havlogen^® Adjuvant

Dose
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in foals and additional boosters will be required in most young animals. For more information on revaccination frequency, consult your veterinarian.